# BLS Labs LLC – FDA Inspection, Jun 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/bls-labs-llc/4b110f0d-34c9-421a-b5db-681e4ae284aa
Source feed: FDA_Inspections

> FDA inspection 1324210 of BLS Labs LLC, June 17, 2026. 1 citation under 21 CFR part 1271. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1324210
- Company Name: BLS Labs LLC
- Inspection Date: 2026-06-17
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Denver District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1086867 - 2019-04-11](https://www.keypedia.com/records/fda_inspections/bls-labs-llc/b8e651ca-06c8-4243-9ed9-9b749884440c)

## Related Officers

- [Investigator](https://www.keypedia.com/people/garrad-r-poole/7fc97953-367e-459b-905d-25efe6ec39d2)
- [Investigator](https://www.keypedia.com/people/paul-m-chefor/96bea4a8-b1ee-4870-ae8b-24794c67da21)

Company: https://www.keypedia.com/companies/bls-labs-llc/1a01f0f8-8122-4ae7-a84e-51bd4b180822

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face